| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President and CSO | See Remarks | Chief Scientific Officer
1 company
Daniel L. Alkon last filed a Form 4 in December 2022, as President and CSO at TAOX. Daniel L. Alkon's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 35,546 shares of TAOX. The TAOX filings lean toward selling, a net 9,688 shares.
Daniel L. Alkon has 4 Form 4 filings on record from June 2021 to December 2022, all as President and CSO at TAO Synergies (TAOX), 2021–2022.
The 4 reported transactions were 1 open-market sale, 1 option or other derivative award, 1 stock award and 1 open-market purchase.
Counted by filing, the open-market trades come to 1 purchase worth about $83K and 1 sale worth about $23K.
The only open-market purchase was 10,000 shares of TAOX at an average $8.26 on June 14, 2021, about $83K. Twelve months later TAOX was down 38%.
The only open-market sale was 19,688 shares of TAOX at an average $1.17 on December 16, 2022, about $23K. Twelve months later TAOX was down 77%.
Shares as reported in the last Form 4 for each company; the most recent is from December 2022. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.